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ABSTRACT 
The controlled drug delivery in drug eluting stents exerts an important influence in 
decreasing restenosis in intravascular stenting. These stents are coated with drug to avoid the re-
narrowing of the arterial wall. The drug is directly associated with the original bare metal stents. 
Drug eluting stents have plus point of a flexible time delivery of a curative drug to the 
neighboring arterial tissue. It treats the required injuries efficiently having negligible systemic 
drug interaction. This thesis aims to develop a mathematical model for describing the procedure 
of drug distribution from stent coating and from arterial wall. For this purpose, a mathematical 
model of two phase is presented to simulate the transportation of drug between coating and 
arterial tissue. This two-phase model explores the impact of non-dimensional parameters such as 
solid liquid mass transfer rate   , ratio of accessible void volume to solid volume    and Peclet 
number    on drug release and mass concentrations from coating and tissue layers. For better 
understanding a 2D mathematical model of biodurable stent coating is developed, where the 
intravascular distribution of drug from an implanted drug eluting stent in arterial wall is 
simulated. The model integrates reversible drug binding and diffusion of drug in the stent 
coating. The arterial wall and coating drug diffusivities are examined for the impact of arterial 
drug uptake and drug release in the coating. The diffusion coefficient of drug   , the diffusion 
coefficients of wall   ,    ,     and strut embedment play an important role to regulate the 
drug release. Moreover, a 3D model of mass concentrations and drug release from the cross 
section of artery is investigated. The impact of advective and diffusive velocities is explored and 
these forces can be used to control the mass concentrations of drug. FEM and FDM is used for 
spatial and temporal discretization of model equations. The sequential and parallel algorithms are 
developed for numerical simulations. Furthermore, the motivation for using GPU accelerators 
with CUDA is explained to handle computational complexities. A hybrid CPU/GPU algorithm 
for the proposed models is designed and satisfactory results for parallel performance indicators 
such as; speedups Sp, temporal performance Tp, efficiency Ep and effectiveness Fp are obtained. 
The CN method gives better sequential results because it has less RMSE than GD and BD 
methods. However, the BD method gives good results for parallel indicators because it involves 
less computation than GD and CN methods. The sequential and parallel performance of BM 
method is better as compared to NM and PM methods. The BM method has least RMSE for both 
sequential and parallel algorithms. The parallel performance indicators Sp, Tp, Ep and Fp for BM 
method gives better performance than the other methods. Therefore, it is a superior method than 
the NM and PM methods.  Hybrid algorithms are more efficient in large-scale problem 
simulations as shown in parallel performance results. The governing models in this research 
provide the basis of a design tool for studying and calculating drug distribution in coating and 
arterial wall in the application of stent-based drug delivery. The models propose in this research 
are used for monitoring purpose and to determine drug release, mass transport, visualization and 
observation. The simulations support to offer a good perception into the potential effects of 
different parameters such as   ,   ,   ,   ,   ,    ,     and strut embedment can affect the 
efficiency of drug release.  
vi 
 
 
 
 
ABSTRAK 
Kawalan penghantaran ubat dalam sten elusi ubat menghasilkan pengaruh yang penting 
dalam mengurangkan stenosis semula dalam sten intravaskular. Sten ini disaluti dengan ubat 
untuk mengelakkan penyempitan semula dinding arteri. Ubat ini berkait rapat dengan sten logam 
terdedah asli.  Sten elusi ubat mempunyai kelebihan dari segi masa penghantaran ubat 
penyembuhan yang fleksibel kepada tisu arterial bersebelahan. Ia merawat kecederaan secara 
efisien dengan interaksi ubat bersistem yang sedikit. Tesis ini bertujuan untuk membangunkan 
model matematik untuk menerangkan prosedur pengagihan ubat dari salutan sten dan dinding 
arteri. Bagi tujuan ini, model matematik dua fasa dikemukakan untuk simulasi pengangkutan 
ubat dari salutan ke tisu arteri. Model matematik dua fasa ini meneroka impak parameter tanpa 
matra seperti kadar pemindahan jisim antara pepejal dan cecair   , nisbah isipadu kosong yang 
boleh diakses dengan isipadu pepejal,    dan nombor Peclet,    terhadap pelepasan ubat dan 
kepekatan jisim daripada salutan dan lapisan tisu. Untuk pemahaman yang lebih baik, satu model 
matematik 2D bagi sten bersalut biotahan lama telah dibangunkan, di mana pengagihan ubat 
secara intravaskular daripada sten elusi ubat yang diimplan dalam dinding arteri telah 
disimulasikan. Model ini mengintegrasikan ikatan ubat boleh balik dan penyerapan ubat dalam 
salutan sten. Penyerapan ubat di dinding arteri dan penyerapan ubat salutan diperiksa untuk 
impak penyerapan ubat arteri dan pelepasan ubat dari salutannya. Pekali penyerapan ubat   , 
pekali penyerapan dinding   ,    ,     dan penyemakan topang memainkan peranan penting 
untuk mengawal pelepasan ubat. Tambahan pula, suatu model 3D untuk pengaruh kepekatan 
jisim dan pelepasan ubat daripada keratan rentas arteri dikaji. Impak hadlaju advektif dan 
penyerapan diterokai dan daya ini boleh digunakan untuk mengawal kepekatan jisim ubat. FEM 
dan FDM digunakan untuk  pendiskretan persamaan model secara ruangan dan secara temporal. 
Algoritma berturut dan selari telah dibangun bagi simulasi berangka. Selain itu, dorongan untuk 
menggunakan pemecut GPU dengan CUDA diterangkan bagi mengendalikan kerumitan 
komputasi. Algoritma hibrid CPU/GPU telah dibentuk bagi model yang dicadangkan dan 
memperoleh hasil prestasi selari memuaskan seperti kelajuan tambahan Sp, prestasi temporal Tp, 
kecekapan Ep dan keberkesanan Fp. Kaedah CN memberi hasil berturut yang lebih baik kerana ia 
mempunyai RMSE yang kurang daripada kaedah GD dan BD. Namun, kaedah BD memberikan 
hasil selari yang lebih baik kerana kaedah ini melibatkan pengiraan yang kurang berbanding 
kaedah GD dan CN. Prestasi berturut dan selari bagi kaedah BM adalah lebih baik berbanding 
kaedah NM dan PM. Kaedah BM mempunyai RMSE yang terkecil bagi algoritma berturut dan 
selari. Indikator prestasi selari Sp, Tp, Ep dan Fp yang ditunjukkan oleh kaedah BM adalah lebih 
baik berbanding kaedah lain. Oleh itu, ia adalah kaedah yang lebih unggul berbanding kaedah 
NM dan PM. Algoritma hibrid adalah lebih cekap dalam simulasi masalah berskala besar seperti 
yang ditunjukkan dalam hasil prestasi selari. Model tadbir dalam kajian ini menyediakan asas 
reka bentuk alat bagi mempelajari dan mengira pengagihan ubat dalam salutan dan dinding arteri 
dalam aplikasi penghantaran ubat berdasarkan sten. Model yang dicadangkan dalam kajian ini 
digunakan untuk tujuan pemantauan dan untuk menentukan pelepasan ubat, pengangkutan jisim, 
visualisasi dan pemerhatian.   Simulasi dapat menyokong persepsi yang baik mengenai kesan 
potensi parameter berbeza seperti   ,   ,   ,   ,   ,    ,     dan pembenaman topang yang 
boleh mempengaruhi kecekapan pelepasan ubat. 
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CHAPTER 1 
 
 
 
1 INTRODUCTION 
1.1 Introduction 
Endovascular drug eluting stents are being increasingly applicable for the 
prevention and cure of restenosis. Stents are devices inserted into arteries to widen 
their lumen, prevent occlusion and restore blood flow perfusion to the tissues 
downstream. Drug Eluting Stents (DES) are coated with drugs for decreasing in-stent 
restenosis after implantation. The drug molecules diffuse from the coating into the 
blood stream and into the artery wall, when a DES is inserted in the artery wall as 
shown in Figure 1.1.  
  
Figure 1.1 A drug eluting stent coated with a drug-loaded polymer and its 
implantation into a stenotic artery. The drug releases from the stent coating into 
artery wall to prevent re-blocking due to restenosis (Vo et al., 2016).  
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Hence, the delivery of drug depends on various aspects, for example 
physicochemical properties and coating geometry, drug properties such as solubility 
and diffusivity. In order to achieve optimum results, the therapeutic agent is loaded 
with biocompatible polymeric layers that are coated on the struts of the stent. These 
stents work under complex conditions that vary according to time and it is not easy to 
accurately predict their efficiency and performance over extended periods of time.  
The following data show the percentage of coronary artery disease in 
population. This percentage is huge in some countries. According to the latest WHO 
data published in May 2016, the death rate due to coronary heart diseases in 
Malaysia has reached 29363 or 23.10% in the world. On average it becomes 150.11 
cases per 100,000 of population. In Pakistan death rate has reached up to 9.87% of 
total deaths. 110.65 fatal cases per 100,000 of population are occurred according to 
data. Death rate in the United States due to heart attacks is, approximately 600,000. It 
is 25% of the total deaths. Among 715,000 Americans who suffered from the heart 
attacks, only 15% of the people die from the stroke. This stroke affects mostly the 
Afro- Americans and the wilds. It may cause 24.3% and 24.1% of deaths, 
respectively.  
Mathematical modeling paves the way of deep perception of the drug 
transport mechanisms in the arterial wall and coating, especially in the drug eluting 
stents case. In this way it has turn into an effective means to catalyze drug release 
processes. In spite of the fact that cardiovascular drug transportation shows a very 
complicated physiological and biochemical phenomenon, yet an improved release 
model may give comprehension of the release mechanism of the drug from arterial 
wall tissue to drug coating. The focus of this research is to aquire the behavior of 
mass transport and drug release from the arteries using mathematical modelling and 
simulation. This chapter highlights the background of the problem, significance and 
scope of the research. Several previous researches will provide an interpretation of 
the background of biodegradable polymer coated drug eluting stents (DES). 
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1.2 Background of Problem 
The background of the problem is divided into two main parts. The first part 
introduces the background of biodegradable polymer coated DES. The second part 
signifies the mass transport from DES.  
1.2.1 Biodegradable Coated Drug Eluting Stents 
This research aims to acquire the behavior of mass transport and drug release 
from the arteries using mathematical modelling and simulation. DES decrease the 
intensity of restenosis as compared to the uncovered metal stents. Nowadays, it 
becomes a widespread method for curing the coronary arteries. 
DES have a metallic wire covered by thin polymer layers. These polymer 
layers enclose a curative drug for the serving hyperplasia of smooth muscle cells. 
The DES performance improved by optimizing the stent geometry and coating 
design. The proceeding of non-proliferative remedial drug  from DES is directly 
related to the rate of the discharge of drug (Tzafriri et al., 2012). Manufacturing and 
design of DES are facing challenges in terms of biological effects and toxicity of the 
local area. The optimum drug concentration and absolute dose of tissue are still not 
enlightened (Venkatraman and Boey, 2007).  
The interaction of the mechanical action of the stent on the wall as well as the 
interface of the blood flow with the drug releasing process from DES are still new in 
the medical literature. These processes had also been analyzed separately in study of 
(Migliavacca et al., 2002; Prosi et al., 2005). The role of drug in healing the artery 
after the insertion and function of the stent is significant  (Migliavacca et al., 2007).  
The flow of blood has a slight effect on the penetration of the drug into the wall.  The 
lumen of artery works to reduce the concentration of the drug. Balakrishnan et al. 
(2005) suggest the justification of these assumptions is not really valued as the drug 
dissolve into the stream of blood. It affects the deposition of the drug in the part of 
the artery walls near the surrounding of the stent. 
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Many issues are directly associated to the slow process of drug release into 
the bio-durable coatings.  The bio-durable or non-erodible polymers are  the most 
frequent kinds of stent coatings to carry the mixtures of  active drug (Lüscher et al., 
2007; Venkatraman and Boey, 2007). This model is being made for the improvement 
of functioning and design of DES. Various researchers have proposed the usage of 
bio-degradable polymer coatings in place of bio-durable coatings (Acharya and Park, 
2006). Biocompatible PLGA (poly lactic-co-glycolic acid), has achieved much 
interest in DES research. PLGA optimize the rates of drug release, based on the 
weights of polymer molecule (Wang et al., 2006).  
Modeling and simulation are used to investigate the distribution of arterial 
drug around the stent strut. The mathematical models reduce the stent coating 
difficulties into a source term and provide improved understanding of drug 
concentration. Such models are used in diffusive and convective  transport of drug in 
the arterial wall (Hwang et al., 2001), stent expansion mechanics,  drug distribution 
(Zunino et al., 2009) and effect of blood flow in the arterial wall (Balakrishnan et al., 
2005; Kolachalama et al., 2009).  
 The distribution of arterial drug has been searched by diffusion of the drug in 
the coating and in the arterial wall. Some researchers discussed the features related to 
drug release such as changeable drug bindings, the strut implantation, compression, 
the viscosity of the coating and structure of the arterial wall of different layers 
(Balakrishnan et al., 2007; Mongrain et al., 2007; Zhu et al., 2014). A degradable 
stent coating is formulated artificially by supposing the value of drug diffusion in the 
coating store.  Drug delivery systems have been discussed in numerous models by 
polymer degradation in PLGA (Borghi et al., 2008; Prabhu and Hossainy, 2007; 
Versypt et al., 2013). Currently, there is plenty of models that propose the bio-
durable coating to understand the discharge of drug from the outer layer and later the 
diffusion of drug into the arterial wall. In these model‘s bio-durable coating is clearly 
formulated with constant release and diffusion of drug (Hossainy and Prabhu, 2008; 
Rossi et al., 2012; Zhu and Braatz, 2014a). Such models have not been employed to 
format the intravascular drug delivery from a biodurable stent coating. A systematic 
model for drug release in the PLGA coating is discussed in this work. It connects the 
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drug diffusion to the PLGA degradation and erosion in the arterial wall (Zhu and 
Braatz, 2014b). The movement of drug is formulated as a reversible or two sided 
binding process by Zhu et al. (2014). This study made some improvement in this 
model by considering convection and diffusion in the modeling of the equation for 
free and bound drug. Furthermore, an investigation based on parameters such as drug 
diffusivities, arterial wall diffusivities and strut embedment of stent strut has 
considered. The effect of strut embedment on arterial wall is investigated for three 
cases, no embedment, half embedment and full embedment. 
1.2.2 Mass Transport from Drug Eluting Stents 
The means of mass transport in DES is to transfer drug from the regions of 
high concentration to the low concentration. The presence of gradients of these 
concentrations induces diffusion between the DES and the arterial wall. Mass 
transport can be divided into two types in the human vasculature system. The first 
type is blood side mass transport. Blood side mass transport transfer the drug into the 
lumen vessels subject to the haemodynamic. The ability of DES to deliver accurate 
remedial mass of drug to the wall becomes limited inside the lumen due to the nature 
of blood flow. So, it efficiently takes the drugs away from the affected parts. This 
happens only in those regions where recirculation of blood is high. The second type 
is transport of drug into the arterial wall, known as wall side mass transport. Wall 
side mass transport depends on the structural conditions of the wall and properties of 
the drugs. These properties will determine how the drug are being transferred into the 
arterial wall. If intimal layer of artery wall is damaged , the mass transfer from 
medial layer  is accelerated directly (Hwang et al., 2001).  
Modelling of mass transport into the arterial walls needs powerful 
information about structure of arterial walls. The DES are fixed in seriously blocked 
regions of arteries. Wall side mass transport is directed by two forces, a convective 
pressure oriented force and the diffusive force. A dimensionless parameter known as 
the Peclet number (Pe)s in Equation 1.1, shows the relation of these two forces 
relatively.  
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(1.1) 
Peclet number plays an important role during mass transfer. If Peclet number 
is less than one, the transport of species is dominated by diffusion. If this number is 
greater than one, species are dominated by convection (Friedman, 2012). 
Mathematical studies convey dynamic material related to mass transport and 
enhancement of the functioning of DES. The delivery of medication between the 
tissue coatings of the arterial walls is more important. The distribution of the drug in 
the lumen by blood flow was published in 2007 (Mongrain et al., 2007). The 
publications appeared in 2009 (Zunino et al., 2009)  and 2010 (Vairo et al., 2010) 
may be categorized as possessing a mutual methodology.  
A model is developed to analyze the diffusion controlled drug release by 
taking spatially independent velocity (Hwang et al., 2001). Pontrelli and De Monte 
(2009) has developed a model based on purely mass diffusion. The methodology 
adopted by Pontrelli and de Monte (2007) for the solution of purely mass diffusion 
problem is similar as to dealing with heat conduction problems. Pontrelli and De 
Monte (2010) extends the previous work by taking a porous artery medial layer and 
porous coating of polymer top coat. This model describes the mass transport through 
multiple layers. A boundary layer model is discussed to deal the  drug distribution by 
means of lumen blood flow by Rugonyi (2008). A few publications highlight the  
numerical analysis of drug mass transport from DES in porous arteries (Pontrelli and 
de Monte, 2007; Zunino, 2004). The variation in the construction of the artery wall 
due to stent compression and its effects on drug mass transport have not been 
formatted numerically. O‘Connell and Walsh (2010) have investigated the effect of 
compression on the artery wall by considering porous material. Walsh, specifies the 
artery wall compression and suggests its existence in all DES computational models. 
A 3D purely diffusive mass transport model is presented by taking compressed 
porous media into account and including the compression on artery wall (Denny et 
al., 2013).  
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It is interesting and encouraging to explore the effects of the drug distribution 
and mass transport from DES with the aid of mathematical models. In this study 
three integrated mathematical models for drug release and mass distribution are 
considered. The governing equations and the boundary conditions in non-
dimensional form have been modified to find the broad range of key parameters. In 
this thesis numerical approach is used to solve the governing equations. For this 
purpose, FEM is applied to solve the model problems because FEM is better than the 
other numerical methods such as FDM and FVM. It has capacity to discretized 
complex geometries in an efficient way. This study involves the geometries of stent 
and arteries therefore it is necessary to use FEM. Furthermore, Matlab 2017a, Visual 
Studio 2010 and CUDA Toolkit 5 are used to develop hybrid platform (CPU-GPU) 
to tackle large sparse system of equations.  
1.3 Statement of the Problem  
This study aims to investigate the drug release and mass transfer from a DES. 
The drug mass transfer and drug release both into the wall regions and coating, are 
explored through the aid of some computational tool. Since, the perturbation or 
asymptotic methods are not able to solve the complex fluid flow model.  Numerical 
method seems to be more significant. Therefore, these aims are achieved by 
modeling the governing equations to illustrate the behavior of drug release and mass 
transport from DES. A two phase drug release model and mass transport from DES is 
under exploration. The movement of drug from biodegradable coated DES 
investigated for better understanding by simulation of 2D model. The governing 
equations explain the drug release from biodegradable coated DES. This model tends 
to explain the concentration of free and bound drug into the arterial wall and coating. 
A 3D mathematical model is considered to investigate the mass transport when blood 
stream passing into the lumen. The governing equations are numerically solved by 
applying finite element method. A hybrid platform is developed for large sparse 
system of discretized equations to reduce the computational cost. Further a sincere 
attempt is made to investigate the necessary modifications to make the integrated 
model able to represent dynamics of drug eluting stents. 
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1.4 Objectives of the Study 
The key objectives of this research are to investigate theoretically the 
characteristics and dynamics of drug release and mass transport from DES. This 
study includes the construction of suitable mathematical models by appropriate 
governing equations. These governing equations are solved by applying FEM. The 
objectives are: 
i. To enhance a two phase mathematical model for the exploration of the effects 
of key parameters on free and bound drug release in drug eluting stents. 
ii. To integrate a coupled mathematical model for the exploration of drug release 
from biodurable coating and arterial wall. 
iii. To develop a mathematical model in order to analyze the mass transport from 
arterial wall region and lumen. 
iv. To develop sequential and parallel algorithms for discretized equations using 
numerical methods. 
1.5 Significant of the Study 
The exact mechanism to understand drug transport and mass distribution in 
arteries is complicated and incomplete. The previous researches show only a part of 
this puzzling mystery. It is important to comprehend the development of the DES. A 
new method can be developed to overcome DES issues. Modelling and simulation 
techniques encourage the understanding of the functions of DES and improve the 
efficacy of device. Biodegradable poly coated DES are the best choice to enhance the 
drug transport. DES decrease the combative consequences in stented arteries in 
patients. A full understanding about the formation of stents is essential for the 
prevention of coronary heart diseases. The DES have become the most common 
treatment for the prevention of these diseases. It is significant to increase the 
9 
 
successfulness of this treatment. The study of the dynamic outcome of the DES on 
the targeted site is essential to reduce the percentage of the treatment failure.  
1.6 Scope of the Study 
The Figure 1.2 highlights the scope of the study in detail. 
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Figure 1.2 Scope of research 
The present study focuses on modelling and simulation to encourage the 
understanding of functions of DES. This in turn could potentially facilitates the 
enhancement of device efficacy and ultimately contribute to reduction of the number 
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of heart attacks. The investigation of key parameters may helpful to optimize the 
mass concentration and drug release from coated drug eluting stents.  
The fluid in the arteries is considered as an incompressible Newtonian fluid 
as shown in Figure 1.2. The mass distribution both into the artery walls and lumen is 
considered minutely in this attempt. Three mathematical models with 1D, 2D and 3D 
are considered in Cartesian coordinate systems to simulate the drug release and mass 
transport from DES. The governing equations are numerically solved by using the 
FEM. Linear elements, triangular elements and tetrahedron elements are used to 
discretize 1D, 2D and 3D models respectively. Sequential and parallel algorithms are 
developed for discretized equations. 
The Matlab 2017b software is used for the computation of sequential and 
parallel numerical results. There are several parallel architectures, the most 
widespread many-core architecture are the GPUs (graphics processing units). On the 
other hand, the most common multi-core architecture are the CPUs (central 
processing units). The code executed using hybrid algorithm is compared with its 
respective serial code executed in one CPU core. The advantage of the hybrid 
algorithm implementation is also observed graphically. 
1.7 Organization of Thesis  
This thesis contains seven chapters. These are organized as follows:  
Chapter 1 highlights the introduction, summary of the background, objectives 
and scope of the study, significance of DES, and at the end structural organization of 
thesis.  
Chapter 2 provides an overview of the DES for the treatment of arterial 
problems. Several existing DES; background of this technology; safety and uses, 
future of DES, role of mathematics and review of FEM and time stepping methods 
are briefly discussed in this chapter. The introduction of hybrid platform and its 
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implementation using CUDA are discussed in detail. The parallel performance 
indicators based on speedup, temporal performance, effectiveness and efficiency are 
also presented in this chapter.  
Chapter 3 details the research methodology of the work. The numerical 
background, governing equations, dependence of different parameters of the equation 
and elaborated solution technique have been discussed. The implementation of FEM 
and time stepping methods have also been discussed in this chapter. The contribution 
in this chapter is the modification of 1D, 2D and 3D mathematical models.  
Chapter 4 gives the idea of two phase mathematical model of drug release 
and mass transport from DES. This model has a system of partial differential 
equations (PDEs). The governing equations are spatially discretized by FEM. The 
temporal discretization is made by three different time marching numerical methods. 
These numerical methods are compared on the basis of execution time, number of 
iteration, maximum error and root mean square error. The FEM is parallelized using 
the hybrid platform to improve the performance of the sequential algorithm. The 
parallel performance of numerical methods is compared on base of parallel 
performance indicators such as speedup, efficiency, temporal performance and 
effectiveness. The main contribution in this chapter is comparison of numerical 
results and parallel performance results to investigate the role of key parameters. 
These parameters play an important part in the concentrations of drug and mass 
transport from DES. 
Chapter 5 presents a two dimensional (2D) mathematical model to analyze 
the drug release from biodurable coating and artery wall. The impact of the stent strut 
embedment, varied coating diffusivities and vascular drug diffusivities in the arterial 
wall are focused in this chapter to determine the device efficiency. Numerical 
solutions are obtained using FEM for governing equations. The governing equations 
are spatially discretized using FEM and the time derivative are treated by FDM 
method. The nonlinear system of algebraic equations is solved by three iterative 
methods known as Picard‘s method, Newton‘s Method and Broyden‘s Method. The 
sequential results of iterative methods are compared on the base of execution time, 
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number of iteration, maximum error and root mean square error. The hybrid platform 
is used to overcome computational costs by converting sequential algorithm to 
parallel algorithm. The parallel performance of iterative methods is compared on 
base of parallel performance indicators such as speedup, efficiency, temporal 
performance and effectiveness.  
The contribution of Chapter 6 focuses on the numerical results and parallel 
performance of the sequential and parallel algorithms for three-dimensional model 
(3D). This model is also discretized numerically using FEM. The nonlinear system of 
algebraic equations is solved by three iterative methods as discussed in Chapter 5. 
The sequential and parallel performance results are measured on the base of parallel 
performance indicators. 
 Chapter 7 states the conclusion drawn from the current work and suggests 
possible directions for the future work. 
1.8 Summary 
This chapter presents the introduction and background of the study to observe 
the drug release and mass transport from DES. Problem statement identifying 
research gaps and future calls of previous studies is discussed. The objectives of 
research based on problem statement are identified to fill theoretical gaps. 
Significance, scope of the study and organization of thesis are also enclosed in this 
chapter. 
.
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